AN2 Therapeutics, Inc.

NasdaqGS:ANTX Stock Report

Market Cap: US$138.6m

AN2 Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ANTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Mar 26SellUS$347Sarah WilliamsIndividual327US$1.06
06 Jan 26SellUS$24,962Joshua EizenIndividual24,854US$1.01
06 Jan 26SellUS$9,332Sanjay ChandaIndividual9,251US$1.01
06 Jan 26SellUS$8,883Lucy DayIndividual8,807US$1.01
06 Jan 26SellUS$6,507Stephen PriorIndividual6,462US$1.01
04 Nov 25SellUS$872Stephen PriorIndividual765US$1.14
04 Nov 25SellUS$3,214Joshua EizenIndividual2,819US$1.14
17 Jun 25SellUS$3,118,800BML Capital Management, LLCCompany2,790,000US$1.12

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ANTX?
Owner TypeNumber of SharesOwnership Percentage
Public Companies927,2012.58%
Individual Insiders2,174,2426.04%
General Public4,138,77811.5%
VC/PE Firms5,527,14015.4%
Hedge Funds7,372,11520.5%
Institutions15,856,06944.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.3%.

Top Shareholders

Top 25 shareholders own 79.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.76%
Vivo Capital, LLC
3,153,640US$12.1m0%1.15%
7.82%
Coastlands Capital LP
2,815,900US$10.8m0%no data
6.59%
Adjuvant Capital, LP
2,373,500US$9.1m0%no data
6.48%
Commodore Capital LP
2,333,713US$9.0m0%0.49%
6.17%
Millennium Management LLC
2,222,502US$8.6m2,220%0.01%
4.61%
Spruce Street Capital LP
1,661,073US$6.4m0%1.56%
4.11%
Almitas Capital LLC
1,479,129US$5.7m-50.3%1.08%
3.67%
Eric Easom
1,321,512US$5.1m1.91%no data
3.43%
Mountain Group Capital, LLC
1,234,861US$4.8m0%100.0%
2.81%
Vanguard Capital Management, LLC
1,011,078US$3.9m0%no data
2.78%
Adage Capital Management, L.P.
1,000,000US$3.8m0%0.01%
2.76%
Woodline Partners LP
993,671US$3.8m581%0.01%
2.58%
Brii Biosciences Limited
927,201US$3.6m0%no data
2.08%
Boxer Capital Management, LLC
749,035US$2.9m0%0.39%
1.98%
Stonepine Capital Management LLC
713,845US$2.7m13.7%1.43%
1.93%
Columbia Management Investment Advisers, LLC
696,181US$2.7m0%no data
1.83%
Sio Capital Management, LLC
657,200US$2.5m0%0.36%
1.53%
Joseph Zakrzewski
551,418US$2.1m0%no data
1.46%
Ally Bridge Group
526,315US$2.0m0%0.89%
1.43%
Prosight Management, LP
515,754US$2.0m0%0.36%
1.28%
The Bank of Nova Scotia
459,194US$1.8m0%no data
1.09%
Bank of America Corporation
393,702US$1.5m2.18%no data
1.03%
Aldebaran Capital, LLC
371,770US$1.4m-1.33%1.06%
0.89%
BlackRock, Inc.
318,768US$1.2m-1.41%no data
0.84%
Jane Street Group, LLC
303,649US$1.2m1,590%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/09 07:45
End of Day Share Price 2026/06/09 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AN2 Therapeutics, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Liisa BaykoEvercore ISI
Joseph SchwartzLeerink Partners LLC